▶ 調査レポート

世界の肺がんの診断市場：市場規模・現状・予測
• 英文タイトル：Global Lung Cancer Diagnostics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の肺がんの診断市場：市場規模・現状・予測 / Global Lung Cancer Diagnostics Market Size, Status and Forecast 2019-2025 / QYR9N7484資料のイメージです。• レポートコード：QYR9N7484
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、肺がんの診断のグローバル市場について調査・分析したレポートで、種類別（イムノアッセイ、フローサイトメトリー、ラピッドテスト、分子アッセイ、ティッシュアレイ、その他）、用途別（工業用、健康管理、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・肺がんの診断の世界市場規模
・主要企業別市場シェア
・肺がんの診断の世界市場規模：種類別（イムノアッセイ、フローサイトメトリー、ラピッドテスト、分子アッセイ、ティッシュアレイ、その他）
・肺がんの診断の世界市場規模：用途別（工業用、健康管理、その他）
・肺がんの診断のアメリカ市場規模（種類別、用途別）
・肺がんの診断のヨーロッパ市場規模（種類別、用途別）
・肺がんの診断の中国市場規模（種類別、用途別）
・肺がんの診断の日本市場規模（種類別、用途別）
・肺がんの診断の東南アジア市場規模（種類別、用途別）
・肺がんの診断のインド市場規模（種類別、用途別）
・肺がんの診断の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・肺がんの診断の世界市場予測（2019年-2025年）
・肺がんの診断の地域別市場予測（2019年-2025年）
...

Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.As people’s awareness of cancer increases and technology advances, as well as private and government support, these are some of the factors that are expected to drive market growth.
In 2018, the global Lung Cancer Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lung Cancer Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lung Cancer Diagnostics development in United States, Europe and China.

The key players covered in this study
Roche Diagnostics
BioMérieux
Qiagen
Advpharma
AIT Austrian Institute of Technology
Courtagen Life Sciences
DiagnoCure
BioMark Diagnostics
Mayo Clinic
HalioDx SAS

Market segment by Type, the product can be split into
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other

Market segment by Application, split into
Industrial
Healthcare
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lung Cancer Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Lung Cancer Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lung Cancer Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lung Cancer Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunoassays
1.4.3 Flow Cytometry
1.4.4 Rapid Tests
1.4.5 Molecular Assays
1.4.6 Tissue Arrays
1.4.7 Circulating Tumor Cells
1.4.8 Pharmacodiagnostics
1.4.9 Biomarkers
1.4.10 Other
1.5 Market by Application
1.5.1 Global Lung Cancer Diagnostics Market Share by Application (2014-2025)
1.5.2 Industrial
1.5.3 Healthcare
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lung Cancer Diagnostics Market Size
2.2 Lung Cancer Diagnostics Growth Trends by Regions
2.2.1 Lung Cancer Diagnostics Market Size by Regions (2014-2025)
2.2.2 Lung Cancer Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Lung Cancer Diagnostics Market Size by Manufacturers
3.1.1 Global Lung Cancer Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Lung Cancer Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lung Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Lung Cancer Diagnostics Key Players Head office and Area Served
3.3 Key Players Lung Cancer Diagnostics Product/Solution/Service
3.4 Date of Enter into Lung Cancer Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lung Cancer Diagnostics Market Size by Type (2014-2019)
4.2 Global Lung Cancer Diagnostics Market Size by Application (2014-2019)

5 United States
5.1 United States Lung Cancer Diagnostics Market Size (2014-2019)
5.2 Lung Cancer Diagnostics Key Players in United States
5.3 United States Lung Cancer Diagnostics Market Size by Type
5.4 United States Lung Cancer Diagnostics Market Size by Application

6 Europe
6.1 Europe Lung Cancer Diagnostics Market Size (2014-2019)
6.2 Lung Cancer Diagnostics Key Players in Europe
6.3 Europe Lung Cancer Diagnostics Market Size by Type
6.4 Europe Lung Cancer Diagnostics Market Size by Application

7 China
7.1 China Lung Cancer Diagnostics Market Size (2014-2019)
7.2 Lung Cancer Diagnostics Key Players in China
7.3 China Lung Cancer Diagnostics Market Size by Type
7.4 China Lung Cancer Diagnostics Market Size by Application

8 Japan
8.1 Japan Lung Cancer Diagnostics Market Size (2014-2019)
8.2 Lung Cancer Diagnostics Key Players in Japan
8.3 Japan Lung Cancer Diagnostics Market Size by Type
8.4 Japan Lung Cancer Diagnostics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lung Cancer Diagnostics Market Size (2014-2019)
9.2 Lung Cancer Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Lung Cancer Diagnostics Market Size by Type
9.4 Southeast Asia Lung Cancer Diagnostics Market Size by Application

10 India
10.1 India Lung Cancer Diagnostics Market Size (2014-2019)
10.2 Lung Cancer Diagnostics Key Players in India
10.3 India Lung Cancer Diagnostics Market Size by Type
10.4 India Lung Cancer Diagnostics Market Size by Application

11 Central & South America
11.1 Central & South America Lung Cancer Diagnostics Market Size (2014-2019)
11.2 Lung Cancer Diagnostics Key Players in Central & South America
11.3 Central & South America Lung Cancer Diagnostics Market Size by Type
11.4 Central & South America Lung Cancer Diagnostics Market Size by Application

12 International Players Profiles
12.1 Roche Diagnostics
12.1.1 Roche Diagnostics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lung Cancer Diagnostics Introduction
12.1.4 Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2014-2019)
12.1.5 Roche Diagnostics Recent Development
12.2 BioMérieux
12.2.1 BioMérieux Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lung Cancer Diagnostics Introduction
12.2.4 BioMérieux Revenue in Lung Cancer Diagnostics Business (2014-2019)
12.2.5 BioMérieux Recent Development
12.3 Qiagen
12.3.1 Qiagen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lung Cancer Diagnostics Introduction
12.3.4 Qiagen Revenue in Lung Cancer Diagnostics Business (2014-2019)
12.3.5 Qiagen Recent Development
12.4 Advpharma
12.4.1 Advpharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lung Cancer Diagnostics Introduction
12.4.4 Advpharma Revenue in Lung Cancer Diagnostics Business (2014-2019)
12.4.5 Advpharma Recent Development
12.5 AIT Austrian Institute of Technology
12.5.1 AIT Austrian Institute of Technology Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lung Cancer Diagnostics Introduction
12.5.4 AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2014-2019)
12.5.5 AIT Austrian Institute of Technology Recent Development
12.6 Courtagen Life Sciences
12.6.1 Courtagen Life Sciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lung Cancer Diagnostics Introduction
12.6.4 Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2014-2019)
12.6.5 Courtagen Life Sciences Recent Development
12.7 DiagnoCure
12.7.1 DiagnoCure Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lung Cancer Diagnostics Introduction
12.7.4 DiagnoCure Revenue in Lung Cancer Diagnostics Business (2014-2019)
12.7.5 DiagnoCure Recent Development
12.8 BioMark Diagnostics
12.8.1 BioMark Diagnostics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lung Cancer Diagnostics Introduction
12.8.4 BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2014-2019)
12.8.5 BioMark Diagnostics Recent Development
12.9 Mayo Clinic
12.9.1 Mayo Clinic Company Details
12.9.2 Company Description and Business Overview
12.9.3 Lung Cancer Diagnostics Introduction
12.9.4 Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2014-2019)
12.9.5 Mayo Clinic Recent Development
12.10 HalioDx SAS
12.10.1 HalioDx SAS Company Details
12.10.2 Company Description and Business Overview
12.10.3 Lung Cancer Diagnostics Introduction
12.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2014-2019)
12.10.5 HalioDx SAS Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Lung Cancer Diagnostics Key Market Segments
Table Key Players Lung Cancer Diagnostics Covered
Table Global Lung Cancer Diagnostics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Lung Cancer Diagnostics Market Size Market Share by Type 2014-2025
Figure Immunoassays Figures
Table Key Players of Immunoassays
Figure Flow Cytometry Figures
Table Key Players of Flow Cytometry
Figure Rapid Tests Figures
Table Key Players of Rapid Tests
Figure Molecular Assays Figures
Table Key Players of Molecular Assays
Figure Tissue Arrays Figures
Table Key Players of Tissue Arrays
Figure Circulating Tumor Cells Figures
Table Key Players of Circulating Tumor Cells
Figure Pharmacodiagnostics Figures
Table Key Players of Pharmacodiagnostics
Figure Biomarkers Figures
Table Key Players of Biomarkers
Figure Other Figures
Table Key Players of Other
Table Global Lung Cancer Diagnostics Market Size Growth by Application 2014-2025 (Million US$)
Figure Industrial Case Studies
Figure Healthcare Case Studies
Figure Other Case Studies
Figure Lung Cancer Diagnostics Report Years Considered
Table Global Lung Cancer Diagnostics Market Size 2014-2025 (Million US$)
Figure Global Lung Cancer Diagnostics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lung Cancer Diagnostics Market Size by Regions 2014-2025 (Million US$)
Table Global Lung Cancer Diagnostics Market Size by Regions 2014-2019 (Million US$)
Table Global Lung Cancer Diagnostics Market Share by Regions 2014-2019
Figure Global Lung Cancer Diagnostics Market Share by Regions 2014-2019
Figure Global Lung Cancer Diagnostics Market Share by Regions 2019
Table Market Top Trends
Table Global Lung Cancer Diagnostics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Lung Cancer Diagnostics Market Share by Manufacturers (2014-2019)
Figure Global Lung Cancer Diagnostics Market Share by Manufacturers in 2018
Table Global Lung Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lung Cancer Diagnostics Product/Solution/Service
Table Date of Enter into Lung Cancer Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lung Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Global Lung Cancer Diagnostics Market Size Share by Type (2014-2019)
Figure Global Lung Cancer Diagnostics Market Size Market Share by Type (2014-2019)
Table Global Lung Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Global Lung Cancer Diagnostics Market Size Share by Application (2014-2019)
Figure Global Lung Cancer Diagnostics Market Size Market Share by Application (2014-2019)
Figure Global Lung Cancer Diagnostics Revenue Market Share by Application in 2018
Figure United States Lung Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table United States Key Players Lung Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table United States Key Players Lung Cancer Diagnostics Market Share (2018-2019)
Table United States Lung Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table United States Lung Cancer Diagnostics Market Share by Type (2014-2019)
Table United States Lung Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table United States Lung Cancer Diagnostics Market Share by Application (2014-2019)
Figure Europe Lung Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table Europe Key Players Lung Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table Europe Key Players Lung Cancer Diagnostics Market Share (2018-2019)
Table Europe Lung Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Europe Lung Cancer Diagnostics Market Share by Type (2014-2019)
Table Europe Lung Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Europe Lung Cancer Diagnostics Market Share by Application (2014-2019)
Figure China Lung Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table China Key Players Lung Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table China Key Players Lung Cancer Diagnostics Market Share (2018-2019)
Table China Lung Cancer Diagnostics Market Size by Type (2014-20189) (Million US$)
Table China Lung Cancer Diagnostics Market Share by Type (2014-2019)
Table China Lung Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table China Lung Cancer Diagnostics Market Share by Application (2014-2019)
Figure Japan Lung Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table Japan Key Players Lung Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table Japan Key Players Lung Cancer Diagnostics Market Share (2018-2019)
Table Japan Lung Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Japan Lung Cancer Diagnostics Market Share by Type (2014-2019)
Table Japan Lung Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Japan Lung Cancer Diagnostics Market Share by Application (2014-2019)
Figure Southeast Asia Lung Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lung Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lung Cancer Diagnostics Market Share (2018-2019)
Table Southeast Asia Lung Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Lung Cancer Diagnostics Market Share by Type (2014-2019)
Table Southeast Asia Lung Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Lung Cancer Diagnostics Market Share by Application (2014-2019)
Figure India Lung Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table India Key Players Lung Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table India Key Players Lung Cancer Diagnostics Market Share (2018-2019)
Table India Lung Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table India Lung Cancer Diagnostics Market Share by Type (2014-2019)
Table India Lung Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table India Lung Cancer Diagnostics Market Share by Application (2014-2019)
Figure Central & South America Lung Cancer Diagnostics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lung Cancer Diagnostics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lung Cancer Diagnostics Market Share (2018-2019)
Table Central & South America Lung Cancer Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Lung Cancer Diagnostics Market Share by Type (2014-2019)
Table Central & South America Lung Cancer Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Lung Cancer Diagnostics Market Share by Application (2014-2019)
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2014-2019) (Million US$)
Figure Roche Diagnostics Revenue Growth Rate in Lung Cancer Diagnostics Business (2014-2019)
Table Roche Diagnostics Recent Development
Table BioMérieux Company Details
Table BioMérieux Revenue in Lung Cancer Diagnostics Business (2014-2019)(Million US$)
Figure BioMérieux Revenue Growth Rate in Lung Cancer Diagnostics Business (2014-2019)
Table BioMérieux Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Lung Cancer Diagnostics Business (2014-2019)(Million US$)
Figure Qiagen Revenue Growth Rate in Lung Cancer Diagnostics Business (2014-2019)
Table Qiagen Recent Development
Table Advpharma Company Details
Table Advpharma Revenue in Lung Cancer Diagnostics Business (2014-2019)(Million US$)
Figure Advpharma Revenue Growth Rate in Lung Cancer Diagnostics Business (2014-2019)
Table Advpharma Recent Development
Table AIT Austrian Institute of Technology Company Details
Table AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2014-2019)(Million US$)
Figure AIT Austrian Institute of Technology Revenue Growth Rate in Lung Cancer Diagnostics Business (2014-2019)
Table AIT Austrian Institute of Technology Recent Development
Table Courtagen Life Sciences Company Details
Table Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2014-2019)(Million US$)
Figure Courtagen Life Sciences Revenue Growth Rate in Lung Cancer Diagnostics Business (2014-2019)
Table Courtagen Life Sciences Recent Development
Table DiagnoCure Company Details
Table DiagnoCure Revenue in Lung Cancer Diagnostics Business (2014-2019)(Million US$)
Figure DiagnoCure Revenue Growth Rate in Lung Cancer Diagnostics Business (2014-2019)
Table DiagnoCure Recent Development
Table BioMark Diagnostics Company Details
Table BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2014-2019)(Million US$)
Figure BioMark Diagnostics Revenue Growth Rate in Lung Cancer Diagnostics Business (2014-2019)
Table BioMark Diagnostics Recent Development
Table Mayo Clinic Company Details
Table Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2014-2019)(Million US$)
Figure Mayo Clinic Revenue Growth Rate in Lung Cancer Diagnostics Business (2014-2019)
Table Mayo Clinic Recent Development
Table HalioDx SAS Company Details
Table HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2014-2019)(Million US$)
Figure HalioDx SAS Revenue Growth Rate in Lung Cancer Diagnostics Business (2014-2019)
Table HalioDx SAS Recent Development
Table Global Lung Cancer Diagnostics Market Size by Regions (Million US$) 2019-2025
Figure Global Lung Cancer Diagnostics Market Size Share by Regions (2019-2025)
Figure Global Lung Cancer Diagnostics Market Size Share by Regions in 2025
Figure United States Lung Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lung Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure China Lung Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lung Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lung Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure India Lung Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lung Cancer Diagnostics Market Size Forecast (2019-2025)(Million USD)
Table Global Lung Cancer Diagnostics Market Size by Product (2019-2025) (Million US$)
Figure Global Lung Cancer Diagnostics Market Size by Product (2019-2025)
Figure Global Lung Cancer Diagnostics Market Size by Product in 2025
Table Global Lung Cancer Diagnostics Market Size by Application (2019-2025) (Million US$)
Figure Global Lung Cancer Diagnostics Market Size by Application (2019-2025)
Figure Global Lung Cancer Diagnostics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の肺がん液体バイオプ市場：市場規模・現状・予測
    Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2019-2025
    QYR9N7485 2019年6月14日 105Pages
    当資料は、肺がん液体バイオプのグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・肺がん液体バイオプの世界市場規模
  • 世界の肺がん市場：市場規模・現状・予測
    Global Lung Cancer Market Size, Status and Forecast 2019-2025
    QYR9N7482 2019年6月14日 96Pages
    当資料は、肺がんのグローバル市場について調査・分析したレポートで、種類別（SCLC肺がん、NSCLC肺がん）、用途別（病院と診療所、がん研究センター、実験室）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の肺がんの診断と治療市場：市場規模・現状・予測
    Global Lung Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7483 2019年6月14日 103Pages
    当資料は、肺がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（非小細胞肺がん、小細胞肺がん）、用途別（病院、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の非侵襲的がん診断市場：市場規模・現状・予測
    Global Noninvasive Cancer Diagnostics Market Size, Status and Forecast 2019-2025
    QYR9N7686 2019年6月14日 97Pages
    当資料は、非侵襲的がん診断のグローバル市場について調査・分析したレポートで、種類別（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）、用途別（固形腫瘍、血液がん、肺がん、乳がん、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...
  • 世界の非侵襲がん診断市場：市場規模・現状・予測
    Global Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2019-2025
    QYR9N7685 2019年6月14日 91Pages
    当資料は、非侵襲がん診断のグローバル市場について調査・分析したレポートで、種類別（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）、用途別（血液がん、固形腫瘍、乳がん、肺癌、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界の前立腺がんバイオマーカー市場：市場規模・現状・予測
    Global Prostate Cancer Biomarker Market Size, Status and Forecast 2019-2025
    QYR9N7891 2019年6月14日 97Pages
    当資料は、前立腺がんバイオマーカーのグローバル市場について調査・分析したレポートで、種類別（尿、血液、血清）、用途別（病院、診療所、がん研究所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

  • 世界の女性の健康診断市場：市場規模・現状・予測
    Global Women Health Diagnostics Market Size, Status and Forecast 2019-2025
    QYR9N8207 2019年6月14日 103Pages
    当資料は、女性の健康診断のグローバル市場について調査・分析したレポートで、種類別（乳がんの検査、子宮頸がん検査、骨粗鬆症検査、妊娠と出生率テスト、卵巣がん検査、その他）、用途別（画像診断センター、病院と診療所、ホームケア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の...
  • 世界の前立腺がんのスクリーニング市場：市場規模・現状・予測
    Global Prostate Cancer Screening Market Size, Status and Forecast 2019-2025
    QYR9N7893 2019年6月14日 98Pages
    当資料は、前立腺がんのスクリーニングのグローバル市場について調査・分析したレポートで、種類別（身体検査、実験室テスト、イメージングテスト、グリーソンスコア、TNMスコア、その他）、用途別（病院、診療所、研究室、がん研究所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジ...
  • 世界の精密癌診断テスト市場：市場規模・現状・予測
    Global Precision Cancer Diagnostic Tests Market Size, Status and Forecast 2019-2025
    QYR9N7874 2019年6月14日 111Pages
    当資料は、精密癌診断テストのグローバル市場について調査・分析したレポートで、種類別（イメージング、分子、組織学/細胞診、腫瘍マーカーイムノアッセイ、POC大腸がん検査）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関...
  • 世界の胃がんの検査、治療および予防市場：市場規模・現状・予測
    Global Gastric Cancer Testing, Treatment and Prevention Market Size, Status and Forecast 2019-2025
    QYR9N7225 2019年6月14日 92Pages
    当資料は、胃がんの検査、治療および予防のグローバル市場について調査・分析したレポートで、種類別（検査、治療、予防）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

  • 世界の肺がん液体バイオプ市場：市場規模・現状・予測世界の肺がん液体バイオプ市場：市場規模・現状・予測 In 2018, the global Lung Cancer Liquid Biops market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Lung Cancer Liquid Biops status, future forecast, growth opportunity, key market and key players. Th…
  • 世界の肺がん市場：市場規模・現状・予測世界の肺がん市場：市場規模・現状・予測 Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as prim…
  • 世界の精密癌診断テスト市場：市場規模・現状・予測世界の精密癌診断テスト市場：市場規模・現状・予測 Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves. In 2018, the global Precision Cancer Diagnostic Tests market size was xx million US$ and it is expected to reach xx milli…
  • 世界の非侵襲的がん診断市場：市場規模・現状・予測世界の非侵襲的がん診断市場：市場規模・現状・予測 Non-invasive diagnosis is a procedure of identifying a disease without or with minimal incision of the body. These methods involve different techniques such as identifying genetic structure, biomarkers, changes in molecular biology, along with imaging technologies. Cancer is a disease related to gen…
  • 世界の肺がんの診断と治療市場：市場規模・現状・予測世界の肺がんの診断と治療市場：市場規模・現状・予測 Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung.Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the g…